MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Medscape Hematology-Oncology Headlines' source. Fri, 19 Mar 2010 13:59:05 +0100 http://www.medworm.com/index.php?rid=3379962&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F715638%3Fsrc%3Drss Don’t miss this case study of a patient with advanced illness, pain, and comorbid substance use disorder who was seen in the home care setting. Journal of Hospice and Palliative Nursing (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3379962 Fri, 19 Mar 2010 13:45:34 +0100 3379962 http://www.medworm.com/index.php?rid=3379961&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F715702%3Fsrc%3Drss This article suggests a thorough understanding of the molecular links connecting the circadian clock to the cell cycle and metabolism may provide therapeutic benefit against certain human neoplasias. Nature Reviews Cancer (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3379961 Fri, 19 Mar 2010 13:45:34 +0100 3379961 http://www.medworm.com/index.php?rid=3379960&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F715699%3Fsrc%3Drss This article reviews the data supporting this chemotherapy option. Expert Review of Anticancer Therapy (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3379960 Fri, 19 Mar 2010 13:45:34 +0100 3379960 http://www.medworm.com/index.php?rid=3379959&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F715879%3Fsrc%3Drss Will the growing knowledge of the genetics of gliomas, along with the continuous improvements of MRI, result in increased therapeutic options available for patients? Expert Review of Molecular Diagnostics (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3379959 Fri, 19 Mar 2010 12:40:30 +0100 3379959 http://www.medworm.com/index.php?rid=3366906&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F718424%3Fsrc%3Drss As first-line treatment for progressive chronic lymphocytic leukemia (CLL), cladribine and fludarabine are equally effective and safe in combination with cyclophosphamide, according to phase III trial results. Reuters Health Information (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3366906 Mon, 15 Mar 2010 18:56:36 +0100 3366906 http://www.medworm.com/index.php?rid=3364412&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F718472%3Fsrc%3Drss Using smaller tubes to collect blood does not affect lab results and reduces the amount of blood drawn in intensive care units and other settings. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3364412 Mon, 15 Mar 2010 12:40:13 +0100 3364412 http://www.medworm.com/index.php?rid=3355475&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F717280%3Fsrc%3Drss A presentation of jaundice proves to be a rare case of gastroduodenal plasmacytoma causing extrahepatic biliary obstruction in the course of multiple myeloma. Southern Medical Journal (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3355475 Fri, 12 Mar 2010 13:42:34 +0100 3355475 http://www.medworm.com/index.php?rid=3355476&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F718290%3Fsrc%3Drss Psoriasis is associated with a significantly greater risk of malignancy, including skin and prostate cancer and non-Hodgkin's lymphoma, according to new research presented here at the 68th annual meeting of the American Academy of Dermatology (AAD 2010). Reuters Health Information (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3355476 Thu, 11 Mar 2010 17:31:27 +0100 3355476 http://www.medworm.com/index.php?rid=3347619&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F718235%3Fsrc%3Drss Women who were taking bisphosphonates for osteoporosis had a 30% reduced risk for breast cancer, compared with control subjects not taking these drugs. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3347619 Wed, 10 Mar 2010 13:41:09 +0100 3347619 http://www.medworm.com/index.php?rid=3340314&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F718028%3Fsrc%3Drss A study shows that nonsteroidal anti-inflammatory drugs and statins can nearly halve the risk for esophageal adenocarcinoma in patients taking proton-pump inhibitors for Barrett's esophagus. Reuters Health Information (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3340314 Mon, 08 Mar 2010 13:36:40 +0100 3340314 http://www.medworm.com/index.php?rid=3332401&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F717931%3Fsrc%3Drss A study shows an overall low incidence of major bleeding after imaging-guided percutaneous core needle biopsy, with little effect of recent aspirin therapy. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3332401 Fri, 05 Mar 2010 13:37:24 +0100 3332401 http://www.medworm.com/index.php?rid=3308042&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F715690%3Fsrc%3Drss This article summarizes findings that represent the first major step toward individualized treatment for patients with metastatic colorectal cancer. Journal of the National Cancer Institute (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3308042 Fri, 26 Feb 2010 13:42:21 +0100 3308042 http://www.medworm.com/index.php?rid=3308041&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F714620%3Fsrc%3Drss DNA double strand breaks are discussed in this editorial review. Nature Reviews Cancer (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3308041 Fri, 26 Feb 2010 13:42:21 +0100 3308041 http://www.medworm.com/index.php?rid=3308043&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F717604%3Fsrc%3Drss Is there such a thing as life after life? Radiation oncologist Jeffrey Long, MD, believes that near-death experiences offer scientific evidence of an afterlife. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3308043 Thu, 25 Feb 2010 18:37:25 +0100 3308043 http://www.medworm.com/index.php?rid=3303572&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F716953%3Fsrc%3Drss This study examines therapeutic management and risk to the fetus in pregnant women with advanced melanoma. The British Journal of Dermatology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3303572 Thu, 25 Feb 2010 13:42:12 +0100 3303572 http://www.medworm.com/index.php?rid=3303571&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F717585%3Fsrc%3Drss The cost of adding erlotinib to the treatment of patients with nonsmall cell lung cancer (NSCLC) is about $95,000 per life-year gained. But it is a much better value in certain patients. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3303571 Thu, 25 Feb 2010 13:41:26 +0100 3303571 http://www.medworm.com/index.php?rid=3280903&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F717181%3Fsrc%3Drss Combination therapy was no better than interferon alfa in metastatic renal cell carcinoma (RCC), but each produced a few complete responses. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3280903 Thu, 18 Feb 2010 13:41:07 +0100 3280903 http://www.medworm.com/index.php?rid=3251784&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F716657%3Fsrc%3Drss Acupuncture treatments might provide a safe alternative for women concerned about the effects of antidepressants during pregnancy. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3251784 Tue, 09 Feb 2010 13:40:58 +0100 3251784 http://www.medworm.com/index.php?rid=3236940&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F716453%3Fsrc%3Drss A new study investigates whether or not the symptoms that characterize ovarian cancer (and many other conditions) are predictive of developing the disease. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3236940 Thu, 04 Feb 2010 13:41:25 +0100 3236940 http://www.medworm.com/index.php?rid=3236941&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F716341%3Fsrc%3Drss This is the first approval for a label extension for trastuzumab, which is already marketed for the treatment of HER2-positive breast cancer. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3236941 Tue, 02 Feb 2010 20:49:09 +0100 3236941 http://www.medworm.com/index.php?rid=3209500&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F715930%3Fsrc%3Drss The type of physician that a prostate cancer patient initially sees might be behind the differences in treatment by healthcare facility. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3209500 Wed, 27 Jan 2010 13:41:18 +0100 3209500 http://www.medworm.com/index.php?rid=3194848&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F715653%3Fsrc%3Drss In elderly colorectal cancer patients, a randomized phase 3 trial has shown better outcomes with adjuvant capecitabine and oxaliplatin than with standard 5-fluorouracil and leucovorin. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3194848 Fri, 22 Jan 2010 13:40:31 +0100 3194848 http://www.medworm.com/index.php?rid=3205633&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F715653%3Fsrc%3Drss In elderly colorectal cancer patients, a randomized phase 3 trial has shown better outcomes with adjuvant capecitabine and oxaliplatin than with standard 5-fluorouracil and leucovorin. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3205633 Fri, 22 Jan 2010 13:39:21 +0100 3205633 http://www.medworm.com/index.php?rid=3186555&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F714989%3Fsrc%3Drss This article provides an overview. Liver International (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3186555 Tue, 19 Jan 2010 22:06:27 +0100 3186555 http://www.medworm.com/index.php?rid=3146937&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F714728%3Fsrc%3Drss Exposure to total-body irradiation and abdominal plus chest radiation and a sedentary lifestyle are associated with an increased risk for the subsequent development of cardiovascular disease. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3146937 Thu, 07 Jan 2010 05:31:42 +0100 3146937 http://www.medworm.com/index.php?rid=3143562&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F714173%3Fsrc%3Drss Lung cancer is primarily associated with upper aerodigestive cancer, but its association with gastric cancer necessitates swift evaluation of correlated signs or symptoms. Clinical Lung Cancer (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3143562 Tue, 05 Jan 2010 17:00:00 +0100 3143562 http://www.medworm.com/index.php?rid=3143561&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F714171%3Fsrc%3Drss Metastatic breast cancer first-line treatments with varying dosing frequencies are compared for efficacy and toxicity. Is one regimen superior? Clinical Breast Cancer (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3143561 Tue, 05 Jan 2010 17:00:00 +0100 3143561 http://www.medworm.com/index.php?rid=3143560&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F714168%3Fsrc%3Drss HIV-infected patients in this study were diagnosed and treated for colon adenocarcinoma and tended to have specific clinical and pathological characteristics. How should screening change? Clinical Colorectal Cancer (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3143560 Tue, 05 Jan 2010 17:00:00 +0100 3143560 http://www.medworm.com/index.php?rid=3134293&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F714362%3Fsrc%3Drss Breast cancer pathology and progression are reviewed in this article, along with molecular mechanisms and the most recent findings in the development of associated targeted therapies. Future Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3134293 Thu, 31 Dec 2009 17:00:00 +0100 3134293 http://www.medworm.com/index.php?rid=3124986&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F713972%3Fsrc%3Drss Body weight affects the levothyroxine dose required for treatment of hypothyroidism or thyroid cancer. This analysis looked at weight-based formulae in athyreotic patients, according to their gender and age. Endocrine Practice (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3124986 Mon, 28 Dec 2009 17:00:00 +0100 3124986 http://www.medworm.com/index.php?rid=3112296&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F713744%3Fsrc%3Drss This paper explains the sex differences in lung cancer, including differences in molecular abnormalities, growth factor receptors, hormonal influences, as well as variations in treatment outcomes. Expert Review of Respiratory Medicine (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3112296 Tue, 22 Dec 2009 17:00:00 +0100 3112296 http://www.medworm.com/index.php?rid=3112295&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F713732%3Fsrc%3Drss For potential treatment of cocaine dependence, researchers investigate whether an interaction exists between selegiline and cocaine. BMC Clinical Pharmacology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3112295 Tue, 22 Dec 2009 17:00:00 +0100 3112295 http://www.medworm.com/index.php?rid=3112294&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F713727%3Fsrc%3Drss Learn more about the risk factors for melanoma development. Expert Review of Dermatology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3112294 Tue, 22 Dec 2009 17:00:00 +0100 3112294 http://www.medworm.com/index.php?rid=3102646&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F713649%3Fsrc%3Drss Can vitamin D production in the skin serve as a protective barrier against nonmelanoma skin cancer? Expert Review of Dermatology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3102646 Fri, 18 Dec 2009 17:00:00 +0100 3102646 http://www.medworm.com/index.php?rid=3102645&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F713644%3Fsrc%3Drss This article discusses how high-throughput screening could be used to identify drugs that target and kill cancer stem cells, which are known to be treatment resistant and able to generate new tumors. Journal of the National Cancer Institute (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3102645 Fri, 18 Dec 2009 17:00:00 +0100 3102645 http://www.medworm.com/index.php?rid=3102644&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F708713%3Fsrc%3Drss Bile proteomics, a field still in its infancy, holds the promise of earlier detection of pancreatic cancer and other difficult-to-diagnose neoplasms. Read this Expert Review to learn more. Expert Review of Proteomics (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3102644 Fri, 18 Dec 2009 17:00:00 +0100 3102644 http://www.medworm.com/index.php?rid=3102643&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F708702%3Fsrc%3Drss Since the initial report of robot-assisted laparoscopic prostatectomy in 2001, the technique has gained rapid acceptance and utilization. But how well does this method work for pelvic lymph node dissection? Prostate Cancer and Prostatic Diseases (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3102643 Fri, 18 Dec 2009 17:00:00 +0100 3102643 http://www.medworm.com/index.php?rid=3085491&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F711388%3Fsrc%3Drss Do genetic polymorphisms have the potential to revolutionize prostate cancer screening by allowing the personalization of early detection? Future Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3085491 Mon, 14 Dec 2009 17:00:00 +0100 3085491 http://www.medworm.com/index.php?rid=3083450&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F713783%3Fsrc%3Drss New results coming from 2 large trials with exemestane suggest that this aromatase inhibitor differs from the other 2 products on the market. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3083450 Mon, 14 Dec 2009 13:36:22 +0100 3083450 http://www.medworm.com/index.php?rid=3076689&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F713692%3Fsrc%3Drss It is well established that regular alcohol intake is associated with an increased risk for breast cancer. Less is known about the way alcohol affects outcomes in women who already have breast cancer. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3076689 Fri, 11 Dec 2009 13:36:02 +0100 3076689 http://www.medworm.com/index.php?rid=3053662&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F712991%3Fsrc%3Drss How does a delay to formalin fixation affect biomarkers? What is the effect on breast cancer patients? Modern Pathology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3053662 Fri, 04 Dec 2009 13:37:57 +0100 3053662 http://www.medworm.com/index.php?rid=3049486&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F712989%3Fsrc%3Drss Although screening can reduce CRC mortality, participation rates are suboptimal. Take a look at what modifiable factors could be targeted in interventions aimed at increasing participation rates. Future Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3049486 Thu, 03 Dec 2009 13:41:44 +0100 3049486 http://www.medworm.com/index.php?rid=3049485&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F712372%3Fsrc%3Drss African-American men are 60 percent more likely develop and die from prostate cancer. Are spiritually based education methods more likely to reach this population? Urologic Nursing (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3049485 Thu, 03 Dec 2009 13:36:17 +0100 3049485 http://www.medworm.com/index.php?rid=3040578&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F711387%3Fsrc%3Drss This study evaluated the clinical and financial outcomes of intraoperative cell salvage (ICS) during abdominal aortic surgery. Vascular (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3040578 Mon, 30 Nov 2009 17:00:00 +0100 3040578 http://www.medworm.com/index.php?rid=3037464&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F713106%3Fsrc%3Drss Exposure to embalming and the duration of embalming practice were associated with an increased risk for mortality from myeloid leukemia. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3037464 Mon, 30 Nov 2009 13:36:19 +0100 3037464 http://www.medworm.com/index.php?rid=3031548&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F713081%3Fsrc%3Drss More than $112 million has been awarded to 2 women who claim that their breast cancer was caused by the hormone replacement therapy (HRT) they took for menopausal symptoms. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3031548 Fri, 27 Nov 2009 13:37:31 +0100 3031548 http://www.medworm.com/index.php?rid=3027442&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F713062%3Fsrc%3Drss These tumors have been considered radioresistant, but a new study shows that radiation therapy was effective in achieving local control and palliation. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3027442 Thu, 26 Nov 2009 12:51:19 +0100 3027442 http://www.medworm.com/index.php?rid=3023859&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F713012%3Fsrc%3Drss Most surgeons treating prostate cancer have very low annual caseloads, which can lead to increased rates of surgical complications and cancer recurrence. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3023859 Wed, 25 Nov 2009 13:38:20 +0100 3023859 http://www.medworm.com/index.php?rid=3005174&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F712292%3Fsrc%3Drss In part 2 of the new series on the Impaired Physician, substance abuse develops in Dr. X. Is it now time to turn him in? Medscape Internal Medicine (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3005174 Wed, 18 Nov 2009 16:17:28 +0100 3005174 http://www.medworm.com/index.php?rid=3005175&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F712162%3Fsrc%3Drss Clinicians often tell patients to save their remaining narcotics for "next time." According to guidelines, this may not be the best advice. Medscape Pharmacists (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=3005175 Wed, 18 Nov 2009 16:07:43 +0100 3005175 http://www.medworm.com/index.php?rid=2994236&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F712402%3Fsrc%3Drss Five-year results show an absolute benefit of 9% for the combination of cetuximab and radiotherapy, compared with radiotherapy alone, in locoregional disease. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2994236 Mon, 16 Nov 2009 13:38:48 +0100 2994236 http://www.medworm.com/index.php?rid=2986060&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F711885%3Fsrc%3Drss How does the expression of sonic hedgehog signaling proteins compare among diffuse large B-cell lymphoma, follicular lymphoma, and chronic lymphocytic leukemia? Modern Pathology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2986060 Fri, 13 Nov 2009 13:40:00 +0100 2986060 http://www.medworm.com/index.php?rid=2978557&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F711286%3Fsrc%3Drss Using a combination of cytotoxic chemotherapies vs sequential single agents in metastatic breast cancer is controversial. The ESO-MBC Task Force provides guidelines and recommendations. Journal of the National Cancer Institute (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2978557 Tue, 10 Nov 2009 17:00:00 +0100 2978557 http://www.medworm.com/index.php?rid=2974661&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F711014%3Fsrc%3Drss Is it primary lung cancer or breast cancer metastatic to the lung? This mathematical and probabilistic model may help in the differential diagnosis. American Journal of Clinical Pathology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2974661 Tue, 10 Nov 2009 13:29:07 +0100 2974661 http://www.medworm.com/index.php?rid=2972423&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F712004%3Fsrc%3Drss Patients with inoperable stage IA nonsmall-cell lung cancer (NSCLC) but good lung function who undergo radial stereotactic radiosurgery show good long-term overall survival rates. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2972423 Mon, 09 Nov 2009 13:33:21 +0100 2972423 http://www.medworm.com/index.php?rid=2964387&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F710291%3Fsrc%3Drss Computer-aided evaluation programs developed for breast MRI provide automated image processing and kinetic analysis and are increasingly used in clinical practice. But how useful are they? American Journal of Roentgenology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2964387 Fri, 06 Nov 2009 13:42:19 +0100 2964387 http://www.medworm.com/index.php?rid=2964385&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F711937%3Fsrc%3Drss Cervical tissue samples that are too small are not appropriate to assess for p16 positivity; the use of the p16 assay on limited samples could lead to the overdiagnosis of endocervical cancer. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2964385 Fri, 06 Nov 2009 13:33:10 +0100 2964385 http://www.medworm.com/index.php?rid=2964386&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F711935%3Fsrc%3Drss The identification of the elements within the volcanic environment that might be responsible could eventually help in developing prevention measures, say researchers. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2964386 Fri, 06 Nov 2009 12:17:17 +0100 2964386 http://www.medworm.com/index.php?rid=2964388&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F711284%3Fsrc%3Drss Prospectively collected resource utilization and health utility data for patients with CRC in the CO.17 study who received best supportive care +/- cetuximab were assessed for cost effectiveness. Journal of the National Cancer Institute (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2964388 Tue, 03 Nov 2009 17:00:00 +0100 2964388 http://www.medworm.com/index.php?rid=2951656&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F711011%3Fsrc%3Drss Immunohistochemical assessment of cell cycle proteins may help distinguish normal and benign conditions of the cervix from precursor lesions of cervical carcinoma. American Journal of Clinical Pathology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2951656 Tue, 03 Nov 2009 13:42:44 +0100 2951656 http://www.medworm.com/index.php?rid=2951655&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F711284%3Fsrc%3Drss Prospectively collected resource utilization and health utility data for patients with CRC in the CO.17 study who received best supportive care +/- cetuximab were assessed for cost effectiveness. Journal of the National Cancer Institute (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2951655 Tue, 03 Nov 2009 13:33:04 +0100 2951655 http://www.medworm.com/index.php?rid=2951657&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F711113%3Fsrc%3Drss In her first Medscape video blog, Dr. Kathy Miller asks whether doctors should avoid using the term “cured” to describe patients who have been in remission for several years. Medscape Hematology-Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2951657 Mon, 02 Nov 2009 21:30:57 +0100 2951657 http://www.medworm.com/index.php?rid=2949072&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F711603%3Fsrc%3Drss Lynch syndrome patients enrolled in an "unsuccessful" trial are demonstrating lower rates of colorectal cancer 4 years after the aspirin study's initiation. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2949072 Mon, 02 Nov 2009 13:33:42 +0100 2949072 http://www.medworm.com/index.php?rid=2940665&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F710290%3Fsrc%3Drss This study provides some answers. American Journal of Roentgenology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2940665 Fri, 30 Oct 2009 12:34:43 +0100 2940665 http://www.medworm.com/index.php?rid=2940666&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F711470%3Fsrc%3Drss Nulliparity and late-life first childbirth are associated with more aggressive breast cancer, according to Swedish researchers. Reuters Health Information (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2940666 Thu, 29 Oct 2009 15:58:16 +0100 2940666 http://www.medworm.com/index.php?rid=2936030&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F709175%3Fsrc%3Drss Investigators sought to identify host genetic polymorphisms associated with the efficacy or hematologic toxicity of IFN-based combination therapy in chronic hepatitis C patients. Journal of Viral Hepatitis (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2936030 Thu, 29 Oct 2009 05:31:24 +0100 2936030 http://www.medworm.com/index.php?rid=2928249&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F710604%3Fsrc%3Drss What leukemia-associated antigen peptides might be useful in a vaccine to reduce the risk of relapse after chemotherapy or stem-cell transplantation? Expert Review of Vaccines (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2928249 Fri, 23 Oct 2009 16:00:00 +0100 2928249 http://www.medworm.com/index.php?rid=2909830&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F710445%3Fsrc%3Drss The purpose of this article was to review current and emerging data for predicating outcome in patients with melanoma. The British Journal of Dermatology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2909830 Wed, 21 Oct 2009 12:44:10 +0100 2909830 http://www.medworm.com/index.php?rid=2905842&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F709817%3Fsrc%3Drss What is the clinical utility of volume-rendering techniques in the evaluation of skin ulcers, inflammation, trauma, and soft tissue tumors? Applied Radiology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2905842 Tue, 20 Oct 2009 12:41:51 +0100 2905842 http://www.medworm.com/index.php?rid=2895699&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F710662%3Fsrc%3Drss When worrisome prostate cancer variables are present but patients have either negative biopsies or a low-volume tumor, magnetic resonance imaging (MRI) might uncover a hidden tumor. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2895699 Fri, 16 Oct 2009 12:35:27 +0100 2895699 http://www.medworm.com/index.php?rid=2883800&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F709663%3Fsrc%3Drss Commentary on a study on whether the addition of FDG PET to the work-up for surgical resection of liver metastases can reduce futile laparotomies. Medscape Radiology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2883800 Mon, 12 Oct 2009 14:21:54 +0100 2883800 http://www.medworm.com/index.php?rid=2881677&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F710180%3Fsrc%3Drss In his latest video blog, Dr. John Marshall compares the work involved in writing successful grant proposals to the preparations necessary for final exams. Medscape Hematology-Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2881677 Thu, 08 Oct 2009 19:54:02 +0100 2881677 http://www.medworm.com/index.php?rid=2866775&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F710092%3Fsrc%3Drss The vote was 6 to 4 in favor of recommending approval of a pegylated formulation of interferon alfa, which eliminates the need for intravenous infusions. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2866775 Wed, 07 Oct 2009 12:35:12 +0100 2866775 http://www.medworm.com/index.php?rid=2856476&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F709798%3Fsrc%3Drss The use of the prostate-specific antigen (PSA) test for population-based prostate cancer screening in the United States has led to gross overtreatment, but no other tests are currently available. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2856476 Thu, 01 Oct 2009 18:48:47 +0100 2856476 http://www.medworm.com/index.php?rid=2843965&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F709157%3Fsrc%3Drss Investigators examined the frequency of SNP in exon 26 of the MDR1 gene in breast cancer and its role in predicting response to neoadjuvant chemotherapy in breast cancer. Clinical Breast Cancer (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2843965 Wed, 30 Sep 2009 16:00:00 +0100 2843965 http://www.medworm.com/index.php?rid=2843964&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F709422%3Fsrc%3Drss Are patients with alcohol-use disorders more susceptible to developing cancer? Alcohol and Alcoholism (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2843964 Wed, 30 Sep 2009 16:00:00 +0100 2843964 http://www.medworm.com/index.php?rid=2836923&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F708405%3Fsrc%3Drss Investigators assessed the outcomes of auto-hematopoietic stem cell transplantation (HCT) and allo-HCT for various lymphomas, particulary non-Hodgkin lymphoma. Expert Review of Hematology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2836923 Mon, 28 Sep 2009 16:00:00 +0100 2836923 http://www.medworm.com/index.php?rid=2836922&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F708441%3Fsrc%3Drss This study investigated whether mammography screening is associated with optimized treatment and improved survival through multidisciplinary medical care. Breast Cancer Research (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2836922 Mon, 28 Sep 2009 16:00:00 +0100 2836922 http://www.medworm.com/index.php?rid=2829447&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F708595%3Fsrc%3Drss What is the potential role of CD56 immunohistochemical analysis in monitoring residual plasma cell myeloma? American Journal of Clinical Pathology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2829447 Fri, 25 Sep 2009 16:00:00 +0100 2829447 http://www.medworm.com/index.php?rid=2829446&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F709204%3Fsrc%3Drss Commentary on a pilot human study on the potential diagnostic utility of the combined administration of F-18-fluoride and F-18-FDG in a single PET-CT study for the detection of malignant lesions. Medscape Radiology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2829446 Fri, 25 Sep 2009 14:10:54 +0100 2829446 http://www.medworm.com/index.php?rid=2829448&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F708442%3Fsrc%3Drss Is there an association between expression levels of 17 candidate genes and locoregional control post breast-conserving treatment in young women with early-stage breast cancers? Breast Cancer Research (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2829448 Thu, 24 Sep 2009 16:00:00 +0100 2829448 http://www.medworm.com/index.php?rid=2825651&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F708394%3Fsrc%3Drss This article looks at current knowledge about the genetic lesions and molecular processes that determine endocrine resistance in breast cancer and how this may be used to improve therapy. Nature Reviews Cancer (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2825651 Thu, 24 Sep 2009 16:00:00 +0100 2825651 http://www.medworm.com/index.php?rid=2821541&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F708873%3Fsrc%3Drss This article summarizes the different indications for endoscopic treatment of and the recent data on the different endoscopic treatment techniques for early neoplasia arising in Barrett's esophagus. Current Opinion in Gastroenterology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2821541 Tue, 22 Sep 2009 14:55:48 +0100 2821541 http://www.medworm.com/index.php?rid=2815404&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F709319%3Fsrc%3Drss Even after its use was discontinued, aspirin offered protection against colon cancer in individuals with Lynch syndrome. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2815404 Tue, 22 Sep 2009 14:37:05 +0100 2815404 http://www.medworm.com/index.php?rid=2815405&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F708869%3Fsrc%3Drss This study reviews the important changes in concepts of managing Barrett's esophagus with regard to screening, surveillance, biomarkers, and therapies over the past several years. Current Opinion in Gastroenterology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2815405 Mon, 21 Sep 2009 21:33:07 +0100 2815405 http://www.medworm.com/index.php?rid=2808613&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F708443%3Fsrc%3Drss Investigators assessed germline mutations in the BRCA1 and BRCA2 genes and looked for the involvement of these genes in breast tumor development. Breast Cancer Research (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2808613 Thu, 17 Sep 2009 21:59:24 +0100 2808613 http://www.medworm.com/index.php?rid=2808614&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F708604%3Fsrc%3Drss Pivotal presentations from the AACR 100th Annual Meeting 2009 are reviewed, with discussion of scientific findings and their effect on clinical practices and ongoing clinical trials. Expert Review of Molecular Diagnostics (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2808614 Wed, 16 Sep 2009 19:02:59 +0100 2808614 http://www.medworm.com/index.php?rid=2808611&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F708836%3Fsrc%3Drss The EGFR mutation is now testable on a large scale and treatable with gefitinib in patients with lung cancer. Faculty of 1000 Medicine (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2808611 Tue, 15 Sep 2009 19:03:12 +0100 2808611 http://www.medworm.com/index.php?rid=2808612&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F708184%3Fsrc%3Drss This study examined whether IFN-alpha treatment would reduce or postpone the recurrence rate and improve the overall survival rate in patients after TACE treatment of HBV-related unresectable HCC. (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2808612 Mon, 14 Sep 2009 20:35:22 +0100 2808612 http://www.medworm.com/index.php?rid=2783279&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F705783%3Fsrc%3Drss In view of the generally slow-growing nature of these tumors, yearly MRI, neuro-ophthalmologic- and pituitary-function evaluation are appropriate during the first 3–5 years after surgery. Clinical Endocrinology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2783279 Thu, 10 Sep 2009 21:55:26 +0100 2783279 http://www.medworm.com/index.php?rid=2783278&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F708180%3Fsrc%3Drss This article assesses HBV vaccination program strategies in Asia in preventing chronic HBV infection and hepatocellular carcinoma and review strategies in controlling liver disease in chronic HBV. Journal of Gastroenterology and Hepatology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2783278 Thu, 10 Sep 2009 16:34:40 +0100 2783278 http://www.medworm.com/index.php?rid=2783280&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F708054%3Fsrc%3Drss Read this clinical update to learn more about how to optimize therapy for patients by balancing efficacy and toxicity. Pharmacotherapy (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2783280 Thu, 10 Sep 2009 15:07:46 +0100 2783280 http://www.medworm.com/index.php?rid=2779666&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F708048%3Fsrc%3Drss PTSD may be surprisingly prevalent and severe in cancer patients, and may persist among survivors long after primary treatment ends. Oncology Nursing Forum (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2779666 Wed, 09 Sep 2009 21:55:43 +0100 2779666 http://www.medworm.com/index.php?rid=2775938&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F708046%3Fsrc%3Drss Does moisture matter for easing IV insertion? Oncology Nursing Forum (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2775938 Tue, 08 Sep 2009 20:53:46 +0100 2775938 http://www.medworm.com/index.php?rid=2775939&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F708035%3Fsrc%3Drss The effects of treatment-induced diarrhea can range from disruptive to deadly, but evidence supports a variety of interventions--some quite simple. Clinical Journal of Oncology Nursing (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2775939 Tue, 08 Sep 2009 19:59:15 +0100 2775939 http://www.medworm.com/index.php?rid=2775940&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F707629%3Fsrc%3Drss Investigators attempted to describe breast tumor subtypes by common breast cancer risk factors and to determine correlates of subtypes with data from two breast cancer studies within a large HMO. Breast Cancer Research (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2775940 Tue, 08 Sep 2009 14:53:04 +0100 2775940 http://www.medworm.com/index.php?rid=2779667&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F707628%3Fsrc%3Drss This study aimed to classify the molecular subtypes of male breast cancers and to evaluate their association with clinicopathologic features and expression patterns of EGFR and NF-kappaB. Breast Cancer Research (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2779667 Fri, 04 Sep 2009 18:08:00 +0100 2779667 http://www.medworm.com/index.php?rid=2775941&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F707630%3Fsrc%3Drss Investigators examined whether a similar pattern exists in breast cancer incidence in first-degree relatives of breast cancer patients. Breast Cancer Research (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2775941 Thu, 03 Sep 2009 22:39:39 +0100 2775941 http://www.medworm.com/index.php?rid=2773222&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F706968%3Fsrc%3Drss This study assessed the effects of ET-1 on cholangiocarcinoma growth in Mz-ChA-1 cells and nude mice and whether ET-1 regulation of such growth affects changes in VEGF and VEGF receptor expression Liver International (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2773222 Thu, 03 Sep 2009 22:32:13 +0100 2773222 http://www.medworm.com/index.php?rid=2759399&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F708211%3Fsrc%3Drss The FDA announced yesterday it has posted supplemental Q&As on the increased risk for lymphoma and other cancers in children and adolescents receiving the tumor necrosis factor (TNF) blockers infliximab (Remicade), adalimumab (Humira), certolizumab (Cimzia), etanercept (Enbrel), and golimumab (Simponi). Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2759399 Tue, 01 Sep 2009 14:16:20 +0100 2759399 http://www.medworm.com/index.php?rid=2748735&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F707778%3Fsrc%3Drss This article reviews the diagnostic criteria for AIH, the indications for and results of liver transplantation, as well as the management of recurrent AIH. disease. (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2748735 Mon, 31 Aug 2009 21:55:09 +0100 2748735 http://www.medworm.com/index.php?rid=2738945&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F707332%3Fsrc%3Drss Several malignant lesions have been reported in association with tattoos, including basal cell carcinomas, squamous cell carcinomas and melanoma. Dermatology Online Journal (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2738945 Thu, 27 Aug 2009 21:05:14 +0100 2738945 http://www.medworm.com/index.php?rid=2738943&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F707918%3Fsrc%3Drss Which patients are candidates for this nonsurgical procedure for Barrett's esophagus? Medscape Gastroenterology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2738943 Thu, 27 Aug 2009 15:57:36 +0100 2738943 http://www.medworm.com/index.php?rid=2735534&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F706963%3Fsrc%3Drss This study reviews the origin of liver stem cells and its relation to HCC development, summarizes the current cancer stem cell markers in HCC, and discusses their relevance to the treatment of HCC. Liver International (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2735534 Wed, 26 Aug 2009 21:37:37 +0100 2735534 http://www.medworm.com/index.php?rid=2738944&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F707337%3Fsrc%3Drss A case report of a 97-year-old man who died as a result of a severe primary cutaneous B cell lymphoma of the knee. Dermatology Online Journal (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2738944 Wed, 26 Aug 2009 21:23:26 +0100 2738944 http://www.medworm.com/index.php?rid=2731506&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F706850%3Fsrc%3Drss Is brain cancer in children associated with parental exposure to pesticides at home and on the job? Environmental Health Perspectives (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2731506 Tue, 25 Aug 2009 22:14:25 +0100 2731506 http://www.medworm.com/index.php?rid=2731505&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F705618%3Fsrc%3Drss This is a strong study that demonstrates the importance of identify anemia in older patients with atrial fibrillation American Heart Journal (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2731505 Tue, 25 Aug 2009 21:59:14 +0100 2731505 http://www.medworm.com/index.php?rid=2731504&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F707830%3Fsrc%3Drss Recent retrospective cohort data and a prospective randomized sham controlled trial have clearly documented the impact of endoscopic ablation therapy on dysplasia and Barrett’s esophagus (BE). Clinical Gastroenterology and Hepatology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2731504 Tue, 25 Aug 2009 21:38:01 +0100 2731504 http://www.medworm.com/index.php?rid=2731503&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F707831%3Fsrc%3Drss An 83-year-old man treated with continuous ambulatory peritoneal dialysis for 3 years for end-stage renal disease caused by type 2 diabetes and hypertension was admitted with peritonitis. American Journal of Kidney Diseases (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2731503 Tue, 25 Aug 2009 21:36:56 +0100 2731503 http://www.medworm.com/index.php?rid=2728072&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F707600%3Fsrc%3Drss This study takes a closer look at the topic. Gastroenterology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2728072 Fri, 21 Aug 2009 22:07:42 +0100 2728072 http://www.medworm.com/index.php?rid=2728076&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F706172%3Fsrc%3Drss What are the limitations of clinically managing adrenocortical carcinoma? What is known about its carcinogenesis and the gene-expression profiling studies that attempted to address these limitations? Expert Review of Molecular Diagnostics (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2728076 Thu, 20 Aug 2009 21:26:53 +0100 2728076 http://www.medworm.com/index.php?rid=2728074&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F706974%3Fsrc%3Drss Although the disease presents later in men than in women, the presentation of breast cancer is essentially the same in both sexes. Southern Medical Journal (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2728074 Thu, 20 Aug 2009 21:26:11 +0100 2728074 http://www.medworm.com/index.php?rid=2728075&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F706170%3Fsrc%3Drss Which gene -- TOP2A or HER2 -- when amplified or deleted is associated with more responsiveness to anthracycline-containing chemotherapy? Journal of the National Cancer Institute (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2728075 Thu, 20 Aug 2009 20:43:56 +0100 2728075 http://www.medworm.com/index.php?rid=2728073&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F706876%3Fsrc%3Drss This study aimed to assess the mast cell and microvessel densities in the invasive colorectal cancers and to determine their prognostic relevance for survival of the patient with colorectal carcinoma. Journal of Gastroenterology and Hepatology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2728073 Wed, 19 Aug 2009 22:04:36 +0100 2728073 http://www.medworm.com/index.php?rid=2728071&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F707572%3Fsrc%3Drss Among patients with breast and prostate cancers, fatigue experienced during radiation therapy may be linked to activation of the proinflammatory cytokine network and its associated biomarkers. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2728071 Tue, 18 Aug 2009 17:36:24 +0100 2728071 http://www.medworm.com/index.php?rid=2706137&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F707140%3Fsrc%3Drss Intention-to-treat may not be perfect, but it is far better than intention-to-cheat. Medscape Business of Medicine (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2706137 Mon, 17 Aug 2009 16:55:49 +0100 2706137 http://www.medworm.com/index.php?rid=2700796&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F707279%3Fsrc%3Drss Regular aspirin use after a colorectal cancer diagnosis was associated with a lower risk for both overall and cancer-specific mortality. This was particularly true for tumors that overexpress COX-2. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2700796 Tue, 11 Aug 2009 21:43:28 +0100 2700796 http://www.medworm.com/index.php?rid=2700795&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F706008%3Fsrc%3Drss What advances are being made in the discovery of early and novel diagnostic lung cancer biomarkers in the blood? Expert Review of Proteomics (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2700795 Tue, 11 Aug 2009 19:34:45 +0100 2700795 http://www.medworm.com/index.php?rid=2679760&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F706116%3Fsrc%3Drss This review discusses the importance of Hsp90 in cancer metastasis and the therapeutic potential of Hsp90 inhibitors as antimetastasis drugs. Future Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2679760 Fri, 07 Aug 2009 21:43:30 +0100 2679760 http://www.medworm.com/index.php?rid=2675919&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F706098%3Fsrc%3Drss This review article discusses the evidence for neoadjuvant and adjuvant treatment approaches when surgery is chosen as the definitive therapy for high-risk prostate cancer. Expert Review of Anticancer Therapy (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2675919 Thu, 06 Aug 2009 20:06:06 +0100 2675919 http://www.medworm.com/index.php?rid=2675918&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F706504%3Fsrc%3Drss How do long-term results compare for these two approaches in rectal cancer? Annals of Surgery (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2675918 Wed, 05 Aug 2009 21:25:20 +0100 2675918 http://www.medworm.com/index.php?rid=2675922&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F705747%3Fsrc%3Drss This study shows upfront ZA more effectively prevents AI-associated bone loss in postmenopausal, early breast cancer patients than delaying therapy until substantial bone loss or fracture occurs. Clinical Breast Cancer (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2675922 Wed, 05 Aug 2009 19:42:18 +0100 2675922 http://www.medworm.com/index.php?rid=2675921&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F705765%3Fsrc%3Drss Docetaxel is an alternative treatment approach for paclitaxel in women who experienced a paclitaxel-associated hypersensitivity reaction while undergoing chemotherapy for ovarian and endometrial. Clinical Ovarian Cancer (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2675921 Wed, 05 Aug 2009 02:01:17 +0100 2675921 http://www.medworm.com/index.php?rid=2675920&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F706231%3Fsrc%3Drss Could STAT5 signaling be targeted in colorectal cancer? Laboratory Investigation (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2675920 Mon, 03 Aug 2009 19:08:25 +0100 2675920 http://www.medworm.com/index.php?rid=2635580&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F706019%3Fsrc%3Drss Multi-agent chemotherapy alone is rarely sufficient for the preservation of group D eyes. The British Journal of Ophthalmology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2635580 Fri, 24 Jul 2009 19:59:15 +0100 2635580 http://www.medworm.com/index.php?rid=2627788&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F705744%3Fsrc%3Drss This study suggests that breast cancer nomograms developed to predict non-SLN metastases should be used cautiously in SLN-positive patients treated with neoadjuvant chemotherapy. Clinical Breast Cancer (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2627788 Wed, 22 Jul 2009 21:57:40 +0100 2627788 http://www.medworm.com/index.php?rid=2627789&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F705132%3Fsrc%3Drss Patients with advanced renal cell cancer who were ineligible for other sorafenib clinical trials were treated in this single-institution study. Clinical Genitourinary Cancer (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2627789 Wed, 22 Jul 2009 20:29:41 +0100 2627789 http://www.medworm.com/index.php?rid=2623076&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F704792%3Fsrc%3Drss Luteinizing hormone-releasing hormone agonists tamoxifen and goserelin were compared in the treatment of premenopausal women with early breast cancer. How are these agents best used? Journal of the National Cancer Institute (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2623076 Tue, 21 Jul 2009 18:57:52 +0100 2623076 http://www.medworm.com/index.php?rid=2617690&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F590155%3Fsrc%3Drss Current approaches can reduce cardiac damage from these commonly used antineoplastic drugs, and current research is exploring new strategies for early identification and prevention. British Journal of Cardiology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2617690 Thu, 16 Jul 2009 22:00:54 +0100 2617690 http://www.medworm.com/index.php?rid=2617687&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F704863%3Fsrc%3Drss This study offers some betters news for patients with colorectal liver metastases, with HPLN dissection offering the only potential cure. Annals of Surgery (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2617687 Thu, 16 Jul 2009 21:00:12 +0100 2617687 http://www.medworm.com/index.php?rid=2627790&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F704697%3Fsrc%3Drss Do physicians have an ethical obligation to inform patients of hospital outcome disparities for certain cancers? PLoS Medicine (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2627790 Thu, 16 Jul 2009 19:30:31 +0100 2627790 http://www.medworm.com/index.php?rid=2617689&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F704793%3Fsrc%3Drss Does low to moderate alcohol consumption in women increase the risk of certain cancers? How much is safe to drink with regard to cancer risk? Journal of the National Cancer Institute (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2617689 Thu, 16 Jul 2009 19:12:40 +0100 2617689 http://www.medworm.com/index.php?rid=2617688&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F705107%3Fsrc%3Drss Trials of treatment with the AI exemestane and the COX-2 inhibitor celecoxib in the neo-adjuvant and metastatic breast cancer settings are reviewed. Annals of Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2617688 Thu, 16 Jul 2009 18:22:27 +0100 2617688 http://www.medworm.com/index.php?rid=2595431&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F705804%3Fsrc%3Drss Decreases in prostate volume over time and resulting changes in PSA performance may have contributed to the detection of high-grade prostate cancer in the finasteride group of the PCPT. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2595431 Tue, 14 Jul 2009 10:34:18 +0100 2595431 http://www.medworm.com/index.php?rid=2592324&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F705254%3Fsrc%3Drss Dr. Maurie Markman comments on a study published in the Journal of Clinical Oncology demonstrating the clinical utility of testing for genetic variations in the PI3K/PTEN/AKT pathway. Medscape Genomic Medicine (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2592324 Sun, 12 Jul 2009 10:33:13 +0100 2592324 http://www.medworm.com/index.php?rid=2581875&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F704839%3Fsrc%3Drss This report describes for the first time the association of BWS and hypothyroidism in a 25 weeks preterm neonate. Journal of Perinatology : Official Journal of the California Perinatal Association (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2581875 Wed, 08 Jul 2009 22:48:39 +0100 2581875 http://www.medworm.com/index.php?rid=2581877&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F705131%3Fsrc%3Drss Cytotoxic chemotherapy has not been well investigated in non-clear-cell renal cell carcinoma (RCC), but this phase II study assesses the efficacy of carboplatin and paclitaxel in patients with RCC. Clinical Genitourinary Cancer (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2581877 Wed, 08 Jul 2009 22:06:49 +0100 2581877 http://www.medworm.com/index.php?rid=2581878&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F704699%3Fsrc%3Drss The publication status of all efficacy trials carried out in support of new drug approvals from 2001 and 2002 is reviewed. Why are a quarter of trials still unpublished? PLoS Medicine (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2581878 Wed, 08 Jul 2009 21:08:43 +0100 2581878 http://www.medworm.com/index.php?rid=2581876&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F704797%3Fsrc%3Drss Prostate-specific antigen screening advances prostate cancer diagnosis, but does the concept of lead time need further clarification? Journal of the National Cancer Institute (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2581876 Wed, 08 Jul 2009 16:28:01 +0100 2581876 http://www.medworm.com/index.php?rid=2578026&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F704688%3Fsrc%3Drss Human papillomavirus (HPV) genotype distributions in cervical cancer were evaluated by these study authors who used Surveillance, Epidemiology, and End Results (SEER) data. Journal of the National Cancer Institute (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2578026 Tue, 07 Jul 2009 17:21:44 +0100 2578026 http://www.medworm.com/index.php?rid=2574119&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F705061%3Fsrc%3Drss Read this clinical update to learn more about the developing targeted therapies for pancreatic cancer, a devastating illness that is very difficult to treat. Expert Review of Clinical Pharmacology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2574119 Mon, 06 Jul 2009 20:49:35 +0100 2574119 http://www.medworm.com/index.php?rid=2578027&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F590345%3Fsrc%3Drss Lower extremity glomus tumor (GT) diagnosis is often delayed owing to the lack of awareness and low level of suspicion by the treating physician. GT is thought to arise from the nail beds. Vascular (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2578027 Mon, 06 Jul 2009 16:00:00 +0100 2578027 http://www.medworm.com/index.php?rid=2574117&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F705095%3Fsrc%3Drss How is PET scanning currently used in different subtypes of lymphoma, and what are some future possibilities for PET scanning? Expert Review of Hematology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2574117 Mon, 06 Jul 2009 13:58:41 +0100 2574117 http://www.medworm.com/index.php?rid=2564298&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F703469%3Fsrc%3Drss This literature review discusses the theoretical background of 5 alt=alpha minmax_bound=true>-reductase inhibitor (5ARI) treatment for prostatic diseases, and the resulting clinical implications. Prostate Cancer and Prostatic Diseases (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2564298 Wed, 01 Jul 2009 22:43:46 +0100 2564298 http://www.medworm.com/index.php?rid=2574118&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F590126%3Fsrc%3Drss Cardiotoxicity is a side effect from several cytotoxic agents, so how can treatments be planned to maximize treatment goals and minimize cardiotoxic effects? British Journal of Cardiology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2574118 Wed, 01 Jul 2009 02:09:05 +0100 2574118 http://www.medworm.com/index.php?rid=2557595&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F704183%3Fsrc%3Drss A 31-month-old Malawian boy presented with diffuse cervical, axillary, and inguinal lymphadenopathy of several months duration. The Pediatric Infectious Disease Journal® (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2557595 Tue, 30 Jun 2009 19:38:50 +0100 2557595 http://www.medworm.com/index.php?rid=2524420&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F703729%3Fsrc%3Drss The prevalence and predictors of anemia in unselected patients with heart failure (HF) are examined. How common is anemia in outpatients with HF? American Heart Journal (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2524420 Fri, 26 Jun 2009 17:12:16 +0100 2524420 http://www.medworm.com/index.php?rid=2524422&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F704724%3Fsrc%3Drss Pharmacologic agents that are showing promise in the treatment of childhood acute leukemia, including monoclonal antibodies, kinase and protease inhibitors, and more are reviewed in this article. Expert Review of Hematology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2524422 Wed, 24 Jun 2009 18:46:40 +0100 2524422 http://www.medworm.com/index.php?rid=2550813&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F704843%3Fsrc%3Drss Childhood acute lymphoblastic leukemia can be successfully treated using personalized chemotherapy without cranial radiation. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2550813 Wed, 24 Jun 2009 14:08:26 +0100 2550813 http://www.medworm.com/index.php?rid=2487002&cid=s_29479_6_f&fid=29479&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F704519%3Fsrc%3Drss Breast cancer expert Dr. Edith A. Perez reviews the most important and potentially practice-changing information presented at ASCO 2009. Medscape Hematology-Oncology (Source: Medscape Hematology-Oncology Headlines) Medscape Hematology-Oncology Headlines info http://www.medworm.com/rss/comments.php?id=2487002 Tue, 23 Jun 2009 21:34:45 +0100 2487002